{"id": "Zf-sLRUAAAAJ", "citedby": 1954, "citedby5y": 1803, "hindex": 19, "hindex5y": 19, "i10index": 23, "i10index5y": 23, "coauthors": [{"id": "UAcx9iMAAAAJ", "name": "Michael B. Stadler", "affiliation": "Head of Computational Biology, Friedrich Miescher Institute, Basel, Switzerland"}, {"id": "5q0DNGIAAAAJ", "name": "J.Wade Harper", "affiliation": "Professor of Cell Biology"}, {"id": "deuMrq4AAAAJ", "name": "Jeremy L. Jenkins", "affiliation": "Head, Data Science, Novartis Institutes for BioMedical Research"}], "name": "Eric S Fischer", "affiliation": "Associate Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", "interests": [], "cites_per_year": {"2012": 23, "2013": 39, "2014": 73, "2015": 126, "2016": 157, "2017": 185, "2018": 298, "2019": 582, "2020": 452}, "publications": [{"bib": {"title": "Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide", "year": "2014"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:u-x6o8ySG0sC", "citedby": "393"}, {"bib": {"title": "The molecular basis of CRL4 DDB2/CSA ubiquitin ligase architecture, targeting, and activation", "year": "2011"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:u5HHmVD_uO8C", "citedby": "279"}, {"bib": {"title": "Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4CRBN ubiquitin ligase", "year": "2016"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:UeHWp8X0CEIC", "citedby": "176"}, {"bib": {"title": "Crystal structure of the human COP9 signalosome", "year": "2014"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:d1gkVwhDpl0C", "citedby": "145"}, {"bib": {"title": "Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:WF5omc3nYNoC", "citedby": "113"}, {"bib": {"title": "A chemoproteomic approach to query the degradable kinome using a multi-kinase degrader", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:eQOLeE2rZwMC", "citedby": "110"}, {"bib": {"title": "Cullin\u2013RING ubiquitin E3 ligase regulation by the COP9 signalosome", "year": "2016"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:Tyk-4Ss8FVUC", "citedby": "92"}, {"bib": {"title": "Plasticity in binding confers selectivity in ligand-induced protein degradation", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:LkGwnXOMwfcC", "citedby": "86"}, {"bib": {"title": "Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray Syndrome", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:UebtZRa9Y70C", "citedby": "73"}, {"bib": {"title": "Detecting UV-lesions in the genome: The modular CRL4 ubiquitin ligase does it best!", "year": "2011"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:9yKSN-GCB0IC", "citedby": "60"}, {"bib": {"title": "Potent and selective covalent quinazoline inhibitors of KRAS G12C", "year": "2017"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:YsMSGLbcyi4C", "citedby": "49"}, {"bib": {"title": "pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4 CRBN ubiquitin ligase", "year": "2017"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:Y0pCki6q_DkC", "citedby": "49"}, {"bib": {"title": "Structure of the Human cGAS\u2013DNA Complex Reveals Enhanced Control of Immune Surveillance", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:roLk4NBRz8UC", "citedby": "48"}, {"bib": {"title": "Chemically induced degradation of anaplastic lymphoma kinase (ALK)", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:_FxGoFyzp5QC", "citedby": "40"}, {"bib": {"title": "Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:MXK_kJrjxJIC", "citedby": "36"}, {"bib": {"title": "Functional regulation of the DNA damage-recognition factor DDB2 by ubiquitination and interaction with xeroderma pigmentosum group C protein", "year": "2015"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:2osOgNQ5qMEC", "citedby": "34"}, {"bib": {"title": "Development of dual and selective degraders of cyclin\u2010dependent kinases 4 and 6", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:3fE2CSJIrl8C", "citedby": "31"}, {"bib": {"title": "Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:kNdYIx-mwKoC", "citedby": "26"}, {"bib": {"title": "ER Stress Signaling Promotes the Survival of Cancer \u201cPersister Cells\u201d Tolerant to EGFR Tyrosine Kinase Inhibitors", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:ufrVoPGSRksC", "citedby": "25"}, {"bib": {"title": "Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4CRBN activity", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:Se3iqnhoufwC", "citedby": "19"}, {"bib": {"title": "SPLINTS: small-molecule protein ligand interface stabilizers", "year": "2016"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:qjMakFHDy7sC", "citedby": "18"}, {"bib": {"title": "Bruton tyrosine kinase degradation as a therapeutic strategy for cancer", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:8k81kl-MbHgC", "citedby": "17"}, {"bib": {"title": "Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:KlAtU1dfN6UC", "citedby": "11"}, {"bib": {"title": "Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15", "year": "2020"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:Zph67rFs4hoC", "citedby": "9"}, {"bib": {"title": "Exploring Targeted Degradation Strategy for Oncogenic KRASG12C", "year": "2020"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:4DMP91E08xMC", "citedby": "4"}, {"bib": {"title": "Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling", "year": "2020"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:aqlVkmm33-oC", "citedby": "4"}, {"bib": {"title": "Development and Characterization of a Wee1 Kinase Degrader", "year": "2020"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:4TOpqqG69KYC", "citedby": "4"}, {"bib": {"title": "The Crossroads of Ubiquitination and DNA Repair: A Structural Perspective", "year": "2016"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:IjCSPb-OGe4C", "citedby": "2"}, {"bib": {"title": "Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2", "year": "2020"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:mVmsd5A6BfQC", "citedby": "1"}, {"bib": {"title": "Tubulin Resists Degradation by Cereblon-Recruiting PROTACs", "year": "2020"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:9ZlFYXVOiuMC", "citedby": "0"}, {"bib": {"title": "A Rationally Designed Covalent BCL6 Inhibitor that Targets a Ty-rosine Residue in the Homodimer Interface", "year": "2020"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:Wp0gIr-vW9MC", "citedby": "0"}, {"bib": {"title": "Targeting T-ALL Cells with Potent Activators of the PP2A Protein Phosphatase Tumor Suppressor", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:qxL8FJ1GzNcC", "citedby": "0"}, {"bib": {"title": "Functional Characterization of E3 Ligases and Their Regulators: Therapeutic Implications for Development of New Proteolysis-Targeting Chimeric Degraders of Oncoproteins", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:M3ejUd6NZC8C", "citedby": "0"}, {"bib": {"title": "CRISPR studies identify genes preferentially essential for myeloma cells vs. other neoplasias: implications for future therapies selective against MM", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:YOwf2qJgpHMC", "citedby": "0"}, {"bib": {"title": "Molecular markers of myeloma cell sensitivity vs. resistance to heterobifunctional degraders of oncoproteins: therapeutic implications.", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:ULOm3_A8WrAC", "citedby": "0"}, {"bib": {"title": "Principles of small molecule mediateed ubiquitin ligase targeting", "year": "2019"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:QIV2ME_5wuYC", "citedby": "0"}, {"bib": {"title": "Improved methods for generating small molecule degraders and dimerizers", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:_kc_bZDykSQC", "citedby": "0"}, {"bib": {"title": "CRISPR-Based Functional Genomics Studies Reveal Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins \u2026", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:5nxA0vEk-isC", "citedby": "0"}, {"bib": {"title": "Triple Degradation of BTK, IKZF1 and IKZF3 in B-Cell Malignancies", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:0EnyYjriUFMC", "citedby": "0"}, {"bib": {"title": "CRL4CRBN Mediated Degradation of SALL4 Links Thalidomide Syndrome to Duane Radial Ray Syndrome", "year": "2018"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:hqOjcs7Dif8C", "citedby": "0"}, {"bib": {"title": "Genome-Scale Screen Reveals Genes Required for Lenalidomide-Mediated Degradation of Aiolos By CRL4-CRBN", "year": "2016"}, "source": "citations", "id_citations": "Zf-sLRUAAAAJ:W7OEmFMy1HYC", "citedby": "0"}]}